Naz Rahman

Q: What is Naz Rahman's success rate?

Naz Rahman currently has a success rate of 52.81896850200597.

Q: What is the average return of Naz Rahman's calls?

Their stock ratings have generated an average return of 47.855443546141935.

Maxim Group | Healthcare

Naz Rahman is an analyst from Maxim Group specializing in the Healthcare sector. Ranked #1636 out of 4664 analysts, they have issued 6 stock ratings with a success rate of 52.82% and an average return of 47.86%.

With 6 ratings to date, Naz Rahman is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 52.82% and an average return of 47.86%, highlighting promising potential as their track record develops further.

#1636

Out of 4664

Total Ratings

+52.82%

Success Rate

+47.86%

Average Return

Recent Ratings Analysis

ACOG

Buy

May 29, 2026

Target

$12.00

Current

$5.94

Performance

—

Naz Rahman rated ACOG as Buy on May 29, 2026, setting a price target of 12. Shares have remained stable near 5.94, leaving the 12 target still in play.

VRTX

Buy

Mar 18, 2026

Target

$575.00

Current

$447.97

Performance

-0.80%

On Mar 18, 2026, VRTX was given a Buy rating by Naz Rahman, with a target price of 575. The stock traded sideways with a -0.80% move, keeping the bullish thesis unresolved.

NXGL

Buy

Mar 12, 2026

Target

$6.00

Current

$0.60

Performance

-37.10%

NXGL received a Buy rating from Naz Rahman on Mar 12, 2026, aiming for 6. The rating hasn’t played out as hoped, with the stock trading 37.10% below expectations.

SCNX

Buy

Feb 24, 2026

Target

$1.50

Current

$0.42

Performance

8.98%

On Feb 24, 2026, Naz Rahman published a Buy outlook on SCNX, with a target of 1.5. Shares gained 8.98%, underscoring the accuracy of the bullish outlook toward 1.5.

KZIA

Buy

Oct 02, 2025

Target

$20.00

Current

$12.67

Performance

100.79%

Naz Rahman on Oct 02, 2025 assigned KZIA a Buy rating, with a price target of 20. The Buy call aligned well with market performance, producing a gain of 100.79%.

AYTU

Buy

Sep 25, 2025

Target

$7.00

Current

$2.24

Performance

20.43%

On Sep 25, 2025, Naz Rahman reaffirmed AYTU with a Buy rating, targeting 7. The recommendation was supported by strong follow-through as the stock rose from 2.24 to 2.24.

SCPH

Hold

Aug 25, 2025

Target

—

Current

$5.67

Performance

2.72%

SCPH was rated Hold by Naz Rahman on Aug 25, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.

GLMD

Hold

Apr 04, 2025

Target

—

Current

$0.68

Performance

-49.44%

On Apr 04, 2025, Naz Rahman initiated coverage on GLMD with a Hold rating and target of null. The rating matched the stock’s inability to hold above 0.6775.

NVCT

Buy

Apr 02, 2025

Target

$17.00

Current

$10.19

Performance

7.72%

Naz Rahman issued a Buy recommendation for NVCT on Apr 02, 2025, price target set at 17. Investors following the Buy call captured upside momentum, with shares now at 10.19.

SLXN

Buy

Mar 20, 2025

Target

$5.00

Current

$0.43

Performance

-97.43%

On Mar 20, 2025, SLXN was evaluated by Naz Rahman, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

VKTX

Buy

Feb 07, 2025

Target

$70.00

Current

$32.19

Performance

-1.14%

Naz Rahman rated VKTX as Buy on Feb 07, 2025, setting a price target of 70. Shares have remained stable near 32.19, leaving the 70 target still in play.

NRSN

Hold

Dec 16, 2024

Target

—

Current

$0.86

Performance

-2.68%

On Dec 16, 2024, NRSN was given a Hold rating by Naz Rahman, with a target price of null. Market indecision, reflected in sideways trading near 0.86, supported the cautious call.

CING

Buy

Nov 20, 2024

Target

—

Current

$4.34

Performance

-3.13%

CING received a Buy rating from Naz Rahman on Nov 20, 2024, aiming for null. Price action was muted, as shares hovered around 4.34 despite the bullish outlook.

VRPX

Hold

Oct 09, 2024

Target

—

Current

$0.00

Performance

-100.00%

On Oct 09, 2024, Naz Rahman published a Hold outlook on VRPX, with a target of null. Weakness in the stock, now at 0.0001, supported the conservative rating.

ASRT

Buy

Jul 26, 2024

Target

$3.00

Current

$23.44

Performance

-93.10%

Naz Rahman on Jul 26, 2024 assigned ASRT a Buy rating, with a price target of 3. The call has struggled to gain traction, with shares losing 93.10%.

PRFX

Buy

Jun 26, 2024

Target

$2.00

Current

$1.37

Performance

-97.58%

On Jun 26, 2024, Naz Rahman reaffirmed PRFX with a Buy rating, targeting 2. Shares slid 97.58% despite the recommendation, highlighting downside risks.

ALIM

Hold

Jun 25, 2024

Target

—

Current

$5.54

Performance

0.36%

ALIM was rated Hold by Naz Rahman on Jun 25, 2024, with a price objective of null. Flat performance suggests the Hold view was reasonable.

PALI

Buy

May 01, 2024

Target

$22.50

Current

$2.06

Performance

-70.90%

On May 01, 2024, Naz Rahman initiated coverage on PALI with a Buy rating and target of 22.5. The Buy call has yet to be validated as shares remain 20.44 away from the target.

Frequency Asked Questions

Who is Naz Rahman?

Naz Rahman is an analyst from Maxim Group specializing in the Healthcare sector.

What is Naz Rahman's success rate?

Naz Rahman currently has a success rate of +52.82%.

How many ratings has Naz Rahman issued?

Naz Rahman has issued 6 stock ratings so far.

What is the average return of Naz Rahman's calls?

Their stock ratings have generated an average return of +47.86%.

What is Naz Rahman's ranking?

Naz Rahman is ranked #1636 out of 4664 analysts.

What types of ratings does Naz Rahman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Naz Rahman?

You can follow Naz Rahman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Naz Rahman?

Their latest rating was a Buy on ACOG issued on 2026-05-29.